Year |
Citation |
Score |
2017 |
Flandreau EI, Toth M. Animal Models of PTSD: A Critical Review. Current Topics in Behavioral Neurosciences. PMID 28070873 DOI: 10.1007/7854_2016_65 |
0.323 |
|
2015 |
Toth M, Flandreau EI, Deslauriers J, Geyer MA, Mansuy I, Merlo-Pich E, Risbrough V. Overexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26538448 DOI: 10.1038/Npp.2015.338 |
0.671 |
|
2015 |
Flandreau E, Risbrough V, Lu A, Ableitner M, Geyer MA, Holsboer F, Deussing JM. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating. Psychoneuroendocrinology. 53: 16-28. PMID 25575243 DOI: 10.1016/J.Psyneuen.2014.12.005 |
0.715 |
|
2014 |
Toth M, Gresack JE, Bangasser DA, Plona Z, Valentino RJ, Flandreau EI, Mansuy IM, Merlo-Pich E, Geyer MA, Risbrough VB. Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1409-19. PMID 24326400 DOI: 10.1038/Npp.2013.336 |
0.727 |
|
2013 |
Flandreau EI, Bourke CH, Ressler KJ, Vale WW, Nemeroff CB, Owens MJ. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala. Psychoneuroendocrinology. 38: 1349-61. PMID 23267723 DOI: 10.1016/J.Psyneuen.2012.11.020 |
0.591 |
|
2013 |
Sink KS, Walker DL, Freeman SM, Flandreau EI, Ressler KJ, Davis M. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Molecular Psychiatry. 18: 308-19. PMID 22290119 DOI: 10.1038/Mp.2011.188 |
0.641 |
|
2012 |
Gafford GM, Guo JD, Flandreau EI, Hazra R, Rainnie DG, Ressler KJ. Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proceedings of the National Academy of Sciences of the United States of America. 109: 16330-5. PMID 22992651 DOI: 10.1073/Pnas.1119261109 |
0.548 |
|
2012 |
Flandreau EI, Ressler KJ, Owens MJ, Nemeroff CB. Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology. 37: 27-38. PMID 21616602 DOI: 10.1016/J.Psyneuen.2011.04.014 |
0.706 |
|
Hide low-probability matches. |